HCV Cure and Kidney Health: A Prospective, Observational Cohort Study of HCV Genotype 1 and 4 Infected Adults With and Without HIV Infection
Phase of Trial: Phase IV
Latest Information Update: 25 Apr 2018
Price : $35 *
At a glance
- Drugs Elbasvir/grazoprevir (Primary)
- Indications Hepatitis C
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 16 Apr 2018 Status changed from not yet recruiting to recruiting.
- 13 Feb 2018 Planned initiation date changed from 29 Jan 2018 to 1 Mar 2018.